+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Cardiac Marker Testing Market Size, Share & Industry Trends Analysis Report By Disease, By End User, By Product (Reagents & Kits and Instruments), By Biomarker Type, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 105 Pages
  • November 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5709559
The North America Cardiac Marker Testing Market should witness market growth of 7.6% CAGR during the forecast period (2022-2028).

Cardiac biomarkers are crucial for the prompt, accurate diagnosis, treatment, and prognosis of the acute coronary syndrome. The myocardial enzymes, a number of myocardial proteins, peptides, and various other substances were among the many biomarkers that were initially studied. The stable molecules known as microRNAs, which can be found in circulation, are the newest addition to the repertoire.

There are four categories that are identified to be involved in the regulation of the circulatory system, and some of them have promise as early and specific markers of cardiac dysfunction and acute coronary syndrome. The use of microRNAs may provide tailored, precise treatment, as in other areas of medicine. Since now, a multifaceted strategy involving various markers for which troponins are required appears to be the optimal course of action.

Cardiac disorders are the primary cause of death in the United States. In the United States, heart disease was the cause of 1 in 5 fatalities in 2020, taking the lives of almost 697,000 people. Heart disease cost the US $229 billion between 2017 and 2018. This covers the cost of prescription medications, medical expenses, and lost wages due to mortality. The high volume of cardiac marker testing would be performed in the North America region due to this increased prevalence of cardiovascular disorders.

The US market dominated the North America Cardiac Marker Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,149.2 million by 2028. The Canada market is poised to grow at a CAGR of 10.1% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 9.1% during (2022-2028).

Based on Disease, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Atherosclerosis, Acute Coronary Syndrome and Ischemia. Based on End-user, the market is segmented into Laboratory Testing Facilities, Point-of-Care Testing Facilities and Academic Institutions. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Biomarker Type, the market is segmented into Troponin I & T, Creatine kinase-MB(CK-MB), Natriuretic peptide (Bnp Or Nt-Probnp), Myoglobin, High-sensitivity C-reactive protein(hs-CRP) and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.

Scope of the Study

By Disease

  • Myocardial Infarction
  • Congestive Heart Failure
  • Atherosclerosis
  • Acute Coronary Syndrome
  • Ischemia

By End-user

  • Laboratory Testing Facilities
  • Point-of-Care Testing Facilities
  • Academic Institutions

By Product

  • Reagents & Kits
  • Instruments

By Biomarker Type

  • Troponin I & T
  • Creatine kinase-MB(CK-MB)
  • Natriuretic peptide (Bnp Or Nt-Probnp)
  • Myoglobin
  • High-sensitivity C-reactive protein(hs-CRP)
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG (Siemens AG)
  • PerkinElmer, Inc.
  • BioMérieux S.A.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cardiac Marker Testing Market, by Disease
1.4.2 North America Cardiac Marker Testing Market, by End-user
1.4.3 North America Cardiac Marker Testing Market, by Product
1.4.4 North America Cardiac Marker Testing Market, by Biomarker Type
1.4.5 North America Cardiac Marker Testing Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 The Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Trails & Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Cardiac Marker Testing Market by Disease
4.1 North America Myocardial Infarction Market by Country
4.2 North America Congestive Heart Failure Market by Country
4.3 North America Atherosclerosis Market by Country
4.4 North America Acute Coronary Syndrome Market by Country
4.5 North America Ischemia Market by Country
Chapter 5. North America Cardiac Marker Testing Market by End-user
5.1 North America Laboratory Testing Facilities Market by Country
5.2 North America Point-of-Care Testing Facilities Market by Country
5.3 North America Academic Institutions Market by Country
Chapter 6. North America Cardiac Marker Testing Market by Product
6.1 North America Reagents & Kits Market by Country
6.2 North America Instruments Market by Country
Chapter 7. North America Cardiac Marker Testing Market by Biomarker Type
7.1 North America Troponin I & T Market by Country
7.2 North America Creatine kinase-MB(CK-MB) Market by Country
7.3 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
7.4 North America Myoglobin Market by Country
7.5 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Cardiac Marker Testing Market by Country
8.1 US Cardiac Marker Testing Market
8.1.1 US Cardiac Marker Testing Market by Disease
8.1.2 US Cardiac Marker Testing Market by End-user
8.1.3 US Cardiac Marker Testing Market by Product
8.1.4 US Cardiac Marker Testing Market by Biomarker Type
8.2 Canada Cardiac Marker Testing Market
8.2.1 Canada Cardiac Marker Testing Market by Disease
8.2.2 Canada Cardiac Marker Testing Market by End-user
8.2.3 Canada Cardiac Marker Testing Market by Product
8.2.4 Canada Cardiac Marker Testing Market by Biomarker Type
8.3 Mexico Cardiac Marker Testing Market
8.3.1 Mexico Cardiac Marker Testing Market by Disease
8.3.2 Mexico Cardiac Marker Testing Market by End-user
8.3.3 Mexico Cardiac Marker Testing Market by Product
8.3.4 Mexico Cardiac Marker Testing Market by Biomarker Type
8.4 Rest of North America Cardiac Marker Testing Market
8.4.1 Rest of North America Cardiac Marker Testing Market by Disease
8.4.2 Rest of North America Cardiac Marker Testing Market by End-user
8.4.3 Rest of North America Cardiac Marker Testing Market by Product
8.4.4 Rest of North America Cardiac Marker Testing Market by Biomarker Type
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent Strategies and Developments
9.1.5.1 Product Launches and Product Expansions
9.1.5.2 Approvals and Trials
9.1.6 SWOT Analysis
9.2 Siemens Healthineers AG (Siemens AG)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent Strategies and Developments
9.2.5.1 Partnerships, Collaborations, and Agreements
9.2.5.2 Product Launches and Product Expansions
9.2.5.3 Acquisition and Mergers
9.2.6 SWOT Analysis
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent Strategies and Developments
9.4.5.1 Product Launches and Product Expansions
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent Strategies and Developments
9.5.5.1 Partnerships, Collaborations, and Agreements
9.5.5.2 Acquisition and Mergers
9.6 Bio-Rad laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent Strategies and Developments
9.6.5.1 Acquisition and Mergers
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 DiaSorin S.p.A.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.9 PerkinElmer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent Strategies and Developments
9.9.5.1 Product Launches and Product Expansions
9.10. BioMérieux S.A.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent Strategies and Developments
9.10.5.1 Partnerships, Collaborations, and Agreements

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG (Siemens AG)
  • PerkinElmer, Inc.
  • BioMérieux S.A.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • DiaSorin S.p.A.

Methodology

Loading
LOADING...